2 CKD confirmatory secondary endpoints Significant 18% RRR of MACE with Ozempic 2 For adults with T2D and CKD, for a confirmatory secondary endpoint: Time to first occurrence of MACE (CV death, nonfatal MI, or nonfatal stroke) vs placebo when both were added to standard of care 1,2 Time to first MACE 1-3,w-z 1-3,w-z w Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modelled as a competing risk using the Aalen-Johnson estimator
MT2 CAS Number 121062-08-6 Molecular Formula C 50 H 69 N 15 O 9 Molecular Weight 1024.2 g/mol PubChem CID 92432 Exact Mass 1023.54026884 Da Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH 2 Peptide Type Synthetic cyclic heptapeptide Physical Form White to off-white lyophilized powder Purity Refer to batch-specific COA View COA Library Storage Store according to the product label and batch-specific Certificate of Analysis
IGF-1 LR3 may raise more concern around blood sugar changes, growth-factor activity, and improper use by beginners
How Intermittent Fasting Aids Fat Loss The Benefits of Ketosis Ketones reduce inflammation and oxidative stress in the brain, heart and other vital organs, which helps prevent/treat related chronic illnesses such as heart disease and Alzheimers
Individuals with low cortisol have low blood pressure
Most retatrutide-related diarrhea is mild to moderate, peaks during dose escalation, and resolves within 8 to 12 weeks for the majority of participants